What To Know
- This remarkable debut reinforced investor confidence in HANN as a rising healthcare powerhouse in the Mekong River Basin.
- This IPO gives us the resources to strengthen our operations, deliver long-term value to shareholders, and maintain the confidence our patients have placed in us for over 30 years.
Bangkok Business PR News: HANN’s Strong Market Debut
Mukdahan International Hospital Public Company Limited, trading under the abbreviation HANN, entered the Market for Alternative Investment (MAI) with a spectacular opening on August 14, 2025. The stock surged more than 70 percent, closing at 1.19 baht, up 0.70 baht from its IPO price of 0.70 baht. This remarkable debut reinforced investor confidence in HANN as a rising healthcare powerhouse in the Mekong River Basin.
HANN’s IPO was a success as the response was overwhelming
Image Credit: Mukdahan International Hospital Public Company Limited
The stellar opening reflects robust investor sentiment, supported by HANN’s proven track record, strong financial foundation, and growing network of hospitals. According to this Bangkok Business PR News report, the response highlighted the market’s trust in the company’s long-term vision and growth trajectory.
Investor Confidence and IPO Details
Mr. Kittipan Phusanawan, Senior Managing Director of Globlex Securities Co., Ltd., which acted as underwriter and distributor of 160 million IPO shares, revealed that demand far exceeded expectations. He explained that the IPO price was strategically set at a P/E ratio of 11.36, lower than the hospital sector average of 15. Furthermore, nearly 96 percent of shareholder shares are subject to lock-up restrictions, reflecting stability and a commitment to sustainable growth.
Mr. Ekkajak Buaphakdee, Managing Director of Capital One Partners Co., Ltd., who served as financial advisor, stressed that HANN’s competitive advantage lies in its extensive experience, advanced equipment, and specialized medical expertise. He emphasized that the hospital group’s comprehensive services, ranging from routine care to complex disease treatment, position it to deliver strong returns for investors.
CEO Outlines Expansion Strategy
Ms. Prabhasri Suchantabutra, CEO of HANN, stated that the successful market entry marked an important milestone for the company’s growth journey. She confirmed that funds raised will be strategically allocated to expand Mukdahan International Hospital and Dr. Han Hospital in Yasothon Province, including constructing two new medical buildings and investing in high-quality equipment.
“Our mission has always been to deliver trusted healthcare services while advancing medical standards in the Mekong region,” Ms. Prabhasri said. “We are deeply confident in our ability to sustain growth while improving patient outcomes. This IPO gives us the resources to strengthen our operations, deliver long-term value to shareholders, and maintain the confidence our patients have placed in us for over 30 years.”
Established Medical Legacy
HANN’s legacy spans more than three decades, with operations across three affiliated hospitals—Mukdahan International Hospital, Dr. Han Hospital, and Ruam Phaet Yasothon Hospital. Combined, these facilities provide 148 hospital beds and deliver specialized care through 16 medical centers and clinics. The company is recognized for expertise in cardiology, oncology, nephrology, diabetes, and other complex conditions.
HANN caters to a diverse patient base, serving four primary groups: cash-paying patients, insurance clients, government welfare users, and international patients, particularly from Laos. The hospitals hold Hospital Accreditation (HA) Level 2 certification, demonstrating adherence to strict quality and safety standards.
Strong Financial Performance
The company’s half-year financial results for 2025 further validated its growth trajectory. Revenue reached 236.71 million baht, nearly steady compared to the 240.54 million baht earned during the same period in 2024. However, net profit soared by 169 percent, climbing from 7.68 million baht to 20.67 million baht.
This surge in profitability reflects the hospital chain’s ability to optimize resources, strengthen service quality, and balance its multi-segment patient portfolio. HANN has also adopted a dividend policy of distributing at least 40 percent of net profits after tax and reserves, ensuring that shareholders benefit directly from the company’s performance.
Looking Ahead
With its entry into the MAI, HANN has positioned itself as one of the most promising healthcare stocks in Thailand. Its combination of a proven legacy, clear expansion strategy, strong investor confidence, and financial resilience gives it a unique edge. The IPO success is not merely a reflection of short-term excitement but a foundation for long-term sustainable growth.
As healthcare demand continues to rise in Thailand and across the Mekong River Basin, HANN’s vision to expand infrastructure, improve technology, and deliver high-quality care makes it well-placed to thrive in the years ahead. With its patient-centric model, financial discipline, and strategic growth roadmap, the company stands ready to transform into a leading regional healthcare force. For investors, HANN offers not only the promise of consistent returns but also participation in a mission-driven enterprise that prioritizes better health for communities across borders.
For the latest Bangkok Business PR News, keep on logging to Bangkok Business News.
